Ciprofloxacin is a broad spectrum fluoroquinolone antibacterial agent. Since its introduction
in the 1980s, most Gram-negative bacteria have remained highly susceptible to this agent in …

Background Pelvic inflammatory disease (PID) affects 4% to 12% of women of reproductive
age. The main intervention for acute PID is broad‐spectrum antibiotics administered …

Methods A literature search was carried out on Medline using the key words “pelvic
inflammatory disease” and was repeated using authors known to have published studies …

This guideline was produced by the European region of the International Union against
sexually transmitted infections (IUSTI) and refers to ascending infections in the female …

Pelvic inflammatory disease (PID) is the most important complication present in the female
lower genital tract, causing major medical, social and economic problems. Although PID can …

Pelvic inflammatory disease (PID) remains one of the most important consequences of
sexually transmitted infections (STIs) resulting in severe morbidity and acting as the …

Pelvic inflammatory disease (PID) is a gynaecological inflammatory disorder with a high
incidence that can lead to sequelae such as infertility, ectopic pregnancy and chronic pelvic …

Objective To assess the effectiveness and safety of antibiotic regimens used to treat pelvic
inflammatory disease (PID). Design This is a systematic review and meta-analysis of …

A total of 89 patients,(> 18 years), with symptoms of chronic prostatitis and inflammatory
findings as well as the presence of Chlamydia trachomatis confirmed by DNA/RNA DIGENE …

Extracts from “Clinical Evidence”: Pelvic inflammatory disease | The BMJ Skip to main content
Intended for healthcare professionals Access provided by Google Indexer Subscribe My …